Browse Category

Stock Market News 25 December 2025

Opendoor (OPEN) Stock News and Forecasts: Homebuyer.com Acquisition, “Opendoor 2.0” AI Pivot, and the 2026 Outlook (Dec. 25, 2025)

Opendoor (OPEN) Stock News and Forecasts: Homebuyer.com Acquisition, “Opendoor 2.0” AI Pivot, and the 2026 Outlook (Dec. 25, 2025)

December 25, 2025 — Opendoor Technologies Inc. (NASDAQ: OPEN) heads into the holiday break with investors trying to answer a deceptively simple question: is this a meme-stock afterglow… or the early innings of a genuine turnaround? With U.S. markets closed for Christmas Day, OPEN’s most recent trade sits around $6.28 (from the shortened Dec. 24 session), leaving the stock near the middle of a year that’s been anything but normal. The headline is hard to ignore: Opendoor stock is up roughly 293%–294% in 2025, depending on the measurement date used by different outlets. The Motley Fool But underneath that eye-popping
Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings Inc. (NASDAQ: ONDS) heads into the Christmas holiday with investors focused less on day-to-day trading (U.S. markets are closed on December 25) and more on a late‑2025 sequence of contracts, acquisitions, and defense-focused expansion moves that have reshaped the company’s narrative. In the shortened Christmas Eve session (Dec. 24, 2025), ONDS last traded around $9.07. StockAnalysis That price level matters for one simple reason: after a year of dramatic swings, Ondas is now being valued like a company the market expects to become a meaningful player in counter-drone (C‑UAS), autonomous surveillance, and multi-domain robotics—but it still has to
UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

December 25, 2025 — UiPath Inc. (NYSE: PATH) is closing out 2025 in the spotlight after a powerful, index-driven rally that pushed the automation software maker back onto investors’ year-end watchlists. With U.S. markets shut for Christmas Day, the conversation is now shifting from “why it moved” to “what the move changes”—for liquidity, ownership, and expectations heading into 2026. Reuters As of the most recent trade (the shortened Christmas Eve session), UiPath shares were around $17.16, after trading between roughly $16.70 and $17.36. What’s new on Dec. 25, 2025 isn’t a surprise product launch or an earnings shock. It’s a
Tesla Stock News Today (Dec. 25, 2025): TSLA Faces Fresh NHTSA Probe, Q4 Delivery Countdown, and Split Wall Street Forecasts

Tesla Stock News Today (Dec. 25, 2025): TSLA Faces Fresh NHTSA Probe, Q4 Delivery Countdown, and Split Wall Street Forecasts

Tesla, Inc. (NASDAQ: TSLA) stock is entering the Christmas break with a familiar mix of momentum and controversy: a sky-high valuation story tied to autonomy, robotics, and energy storage—colliding with another round of safety scrutiny and ongoing questions about vehicle demand. Because U.S. markets are closed on Thursday, December 25, 2025, there’s no new trading action in TSLA today. The latest price discovery comes from Wednesday’s holiday-shortened session (Dec. 24)—and it arrived just as regulators opened a new investigation into Tesla’s emergency door release design. New York Stock Exchange Below is a full, publication-ready roundup of the most current Tesla
Plug Power Stock (NASDAQ: PLUG) News on Dec. 25, 2025: Latest Catalysts, Analyst Forecasts, and What Investors Are Watching

Plug Power Stock (NASDAQ: PLUG) News on Dec. 25, 2025: Latest Catalysts, Analyst Forecasts, and What Investors Are Watching

December 25, 2025 — U.S. markets are closed for Christmas Day, so the most recent trading for Plug Power Inc. (NASDAQ: PLUG) is from Wednesday, Dec. 24. Plug Power stock last traded around $2.10, up roughly 2.4% on the day, after a choppy stretch that has kept the shares pinned in the low-$2 range. MarketWatch That one-day bounce, though, doesn’t change the bigger picture: Plug’s stock remains deeply volatile and far below its 52-week high of $4.58 (set Oct. 6), reflecting an investor base still split between “turnaround finally working” and “more dilution and delays ahead.” MarketWatch Below is a
NVIDIA Stock News (Dec. 25, 2025): NVDA’s Groq Inference Deal, China H200 Export Twist, and CES 2026 Catalyst

NVIDIA Stock News (Dec. 25, 2025): NVDA’s Groq Inference Deal, China H200 Export Twist, and CES 2026 Catalyst

December 25, 2025 — U.S. markets are closed for Christmas Day, but NVIDIA Corporation (NASDAQ: NVDA) investors have plenty to digest after a headline-heavy week for the AI-chip leader. NVDA last traded around $188.61 in the most recent session available (Christmas Eve trading), as investors weighed fresh deal news, shifting U.S.–China chip policy signals, and a coming spotlight at CES 2026. Investors What follows is a full roundup of the current NVIDIA stock news, analyst forecasts, and market analysis as of 25.12.2025—and what they may signal for NVDA into early 2026. The biggest NVIDIA stock headline: Groq licensing deal (not
25 December 2025
FDA Frozen Shrimp Recall Over Cesium-137: Market 32 and Waterfront Bistro Products Pulled Across 17 States

FDA Frozen Shrimp Recall Over Cesium-137: Market 32 and Waterfront Bistro Products Pulled Across 17 States

Dec. 25, 2025 — If shrimp cocktail, shrimp scampi, or a quick freezer-to-pan seafood dinner is part of your holiday week, check your freezer before you cook. A new FDA-posted recall involves about 83,800 bags of frozen raw shrimp that may have been exposed to cesium-137 (Cs‑137), a man-made radioactive isotope. The recalled shrimp was imported from Indonesia and distributed in the U.S. under Market 32 and Waterfront Bistro labels by Direct Source Seafood LLC of Bellevue, Washington, according to federal and company recall notices. U.S. Food and Drug Administration The FDA and the company stress that this recall is
25 December 2025
Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum

Merck (MRK) Stock News on Dec. 25, 2025: BMO Lifts Target to $130 as FDA Fast-Track Vouchers and Keytruda Data Fuel Momentum

December 25, 2025 — Merck & Co., Inc. (NYSE: MRK) is ending 2025 with something investors tend to enjoy: momentum with a story behind it. Even with U.S. markets closed for Christmas Day, Merck shares are in focus after a late-December climb that pushed the stock to fresh highs, helped along by a major Wall Street upgrade and a burst of pipeline and regulatory headlines. MarketBeat Below is what’s moving Merck stock, what the latest MRK forecasts imply for 2026, and the near-term catalysts (and risks) that could decide whether this rally is the start of a new chapter—or just
Tim Cook Buys $3 Million in Nike Stock as S&P 500 Hits Record Highs; Gold Hovers Near $4,500 in Holiday “Santa Rally” Trade

Tim Cook Buys $3 Million in Nike Stock as S&P 500 Hits Record Highs; Gold Hovers Near $4,500 in Holiday “Santa Rally” Trade

Dec. 25, 2025 — With U.S. markets closed for Christmas Day, investors are spending the holiday digesting a rare combination of headline signals: a high-profile insider buy at Nike by Apple CEO Tim Cook, record closes for the S&P 500 and Dow Jones Industrial Average, and a commodities complex that has turned “year-end” into “record-end,” led by gold’s surge to the doorstep of $4,500 an ounce. CNA The backdrop is classic late-December: light trading volumes, seasonal optimism, and traders watching whether the market can extend the so-called Santa Claus rally window into the final sessions of the year and the
Johnson & Johnson Stock (JNJ) Update: Price, Latest News, Analyst Forecasts and Key Risks on December 25, 2025

Johnson & Johnson Stock (JNJ) Update: Price, Latest News, Analyst Forecasts and Key Risks on December 25, 2025

December 25, 2025 — Johnson & Johnson stock (NYSE: JNJ) is in “holiday mode” today, with U.S. markets closed for Christmas Day after an early close on Christmas Eve. Investopedia The last regular-session print before the holiday was $207.78 (Dec. 24 close), keeping JNJ near the upper end of its 2025 range. Nasdaq+1 That calm surface hides a busy catalyst stack that investors are carrying into the final trading days of 2025 and the first earnings checkpoint of 2026: fresh talc verdict headlines, new FDA-related momentum, Washington drug-pricing politics, and a steady drumbeat of analyst price-target revisions. JNJ stock price
25 December 2025
Disney Stock (DIS) on Dec. 25, 2025: Today’s News, Analyst Forecasts, and What Could Move Shares Next

Disney Stock (DIS) on Dec. 25, 2025: Today’s News, Analyst Forecasts, and What Could Move Shares Next

The Walt Disney Company (NYSE: DIS) heads into the Christmas holiday with its stock perched near the mid-$110s after a strong month—and with Wall Street’s attention split between Disney’s own execution (streaming profitability, parks cash flow, and capital returns) and the industry’s rapidly shifting chessboard (most notably, the Warner Bros. Discovery bidding battle). Nasdaq Disney shares last closed at $114.48 (Dec. 24), capping a roughly 9.6% gain over the past month, according to a widely circulated Zacks/Nasdaq market wrap. Nasdaq Below is a comprehensive roundup of the most current Disney stock news, forecasts, and analyst takes circulating as of 25.12.2025,
25 December 2025
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb Company (NYSE: BMY) heads into Dec. 25, 2025 with its stock anchored in the mid-$50s — and with investors juggling two competing storylines: With U.S. markets effectively pausing for the holiday, the most recent available NYSE quote showed BMY around $54.71 (last trade timestamp recorded Dec. 24), after trading between roughly $54.20 and $54.75 intraday. Bristol Myers Squibb Investors Bristol-Myers Squibb stock price today: where BMY stands into Dec. 25, 2025 BMS’s own investor quote page showed BMY at $54.71 on Dec. 24 (delayed quote), with a prior close listed as $54.28 and a 52-week range of $42.52

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop